HomeHealthcare and Life Sciences Middle East and Africa Mounjaro Market

Middle East and Africa Mounjaro Market Size, Share & Trends Analysis Report By Indication (Type 2 Diabetes, Obesity/Weight Management, Prediabetes/Metabolic Syndrome, Others), By Route of Administration (Injectable, Oral), By Country (Brazil, Mexico, Argentina, Chile, Colombia) and Forecast, 2026-2034

Report Code: SMI3402PUB | Last Updated : 18 August, 2026 | Base Year : 2025 | Historical Data : 2022-2024 | Region : Middle East and Africa | Format : PDF, Excel | Number of Pages : 140 | Author : Jenny Burkett

Table of Contents

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: Middle East and Africa Mounjaro Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on Middle East and Africa Mounjaro Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. Middle East and Africa Mounjaro Market, By Indication
    1. Introduction
      1. Market Size and Forecast, By Indication
    2. Type 2 Diabetes
      1. Market Size and Forecast, By Region
    3. Obesity/Weight Management
      1. Market Size and Forecast, By Region
    4. Prediabetes/Metabolic Syndrome
      1. Market Size and Forecast, By Region
    5. Others
      1. Market Size and Forecast, By Region
  10. Middle East and Africa Mounjaro Market, By Route of Administration
    1. Introduction
      1. Market Size and Forecast, By Route of Administration
    2. Injectable
      1. Market Size and Forecast, By Region
    3. Oral
      1. Market Size and Forecast, By Region
  11. Middle East and Africa Mounjaro Market, By Dosage Strength
    1. Introduction
      1. Market Size and Forecast, By Dosage Strength
    2. 2.5 mg
      1. Market Size and Forecast, By Region
    3. 5 mg
      1. Market Size and Forecast, By Region
    4. 7.5 mg
      1. Market Size and Forecast, By Region
    5. 10 mg
      1. Market Size and Forecast, By Region
    6. 12.5 mg
      1. Market Size and Forecast, By Region
    7. 15 mg
      1. Market Size and Forecast, By Region
  12. Middle East and Africa Mounjaro Market, By Distribution Channel
    1. Introduction
      1. Market Size and Forecast, By Distribution Channel
    2. Retail Pharmacies
      1. Market Size and Forecast, By Region
    3. Hospital Pharmacies
      1. Market Size and Forecast, By Region
    4. Online Pharmacies
      1. Market Size and Forecast, By Region
    5. Specialty Pharmacies
      1. Market Size and Forecast, By Region
  13. Regional Overview
    1. Introduction
      1. Market Size and Forecast
    2. Middle East and Africa
      1. Market Size and Forecast
        1. By Indication
          1. Type 2 Diabetes
            1. Obesity/Weight Management
              1. Prediabetes/Metabolic Syndrome
                1. Others
                2. By Route of Administration
                  1. Injectable
                    1. Oral
                    2. By Dosage Strength
                      1. 2.5 mg
                        1. 5 mg
                          1. 7.5 mg
                            1. 10 mg
                              1. 12.5 mg
                                1. 15 mg
                                2. By Distribution Channel
                                  1. Retail Pharmacies
                                    1. Hospital Pharmacies
                                      1. Online Pharmacies
                                        1. Specialty Pharmacies
                                      2. UAE
                                        1. By Indication
                                          1. Type 2 Diabetes
                                            1. Obesity/Weight Management
                                              1. Prediabetes/Metabolic Syndrome
                                                1. Others
                                                2. By Route of Administration
                                                  1. Injectable
                                                    1. Oral
                                                    2. By Dosage Strength
                                                      1. 2.5 mg
                                                        1. 5 mg
                                                          1. 7.5 mg
                                                            1. 10 mg
                                                              1. 12.5 mg
                                                                1. 15 mg
                                                                2. By Distribution Channel
                                                                  1. Retail Pharmacies
                                                                    1. Hospital Pharmacies
                                                                      1. Online Pharmacies
                                                                        1. Specialty Pharmacies
                                                                      2. Turkey
                                                                      3. Saudi Arabia
                                                                      4. South Africa
                                                                      5. Egypt
                                                                      6. Nigeria
                                                                      7. Rest of MEA
                                                                  2. Competitive Landscape, 2025
                                                                    1. Introduction
                                                                    2. Middle East and Africa Mounjaro Market Share Analysis, 2025 (%)
                                                                      1. Market Share Analysis, 2025
                                                                      2. Competition Ranking, 2025
                                                                      3. Key Developments & Growth Strategies
                                                                        1. Merger & Acquisition
                                                                        2. Product Launch
                                                                        3. Expansion
                                                                      4. Consolidated SWOT Analysis of Key Players
                                                                  3. Company Profile
                                                                    1. Eli Lilly and Company
                                                                      1. Business Overview
                                                                      2. Financial Data
                                                                      3. Key Product domains
                                                                      4. Recent Developments
                                                                    2. Novo Nordisk A/S
                                                                    3. Sanofi S.A.
                                                                    4. AstraZeneca plc
                                                                    5. Boehringer Ingelheim
                                                                    6. Merck & Co., Inc.
                                                                    7. Pfizer Inc.
                                                                    8. Novartis AG
                                                                    9. GSK plc
                                                                    10. Amgen Inc.
                                                                    11. Roche Holding AG
                                                                    12. Zealand Pharma A/S